Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Pointon

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Archives of Toxicology|May 16, 2025
Discovering a predictive metabolic signature of drug-induced structural cardiotoxicity in cardiac microtissuesTara J Bowen, Andrew R Hall, Gavin R Lloyd, et al.
Stem Cell Reports|February 12, 2022
Deriving waveform parameters from calcium transients in human iPSC-derived cardiomyocytes to predict cardiac activity with machine learningHongbin Yang, Will Stebbeds, Jo Francis, et al.
Toxicology and Applied Pharmacology|December 12, 2022
Prediction of inotropic effect based on calcium transients in human iPSC-derived cardiomyocytes and machine learningHongbin Yang, Olga Obrezanova, Amy Pointon, et al.
Nature Communications|August 3, 2023
Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomicsTara J Bowen, Andrew D Southam, Andrew R Hall, et al.
Lab on a Chip|January 20, 2021
Cardiovascular microphysiological systems (CVMPS) for safety studies - a pharma perspectiveAmy Pointon, Jonathan Maher, Myrtle Davis, et al.
ALTEX|May 15, 2024
Application of microphysiological systems for nonclinical evaluation of cell therapiesPelin L Candarlioglu, Louise Delsing, Lauren Gauthier, et al.
Cell Stem Cell|February 17, 2024
Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytesKavita Raniga, Aishah Nasir, Nguyen T N Vo, et al.
Chemical Research in Toxicology|October 24, 2018
Information-Derived Mechanistic Hypotheses for Structural CardiotoxicityFredrik Svensson, Azedine Zoufir, Samar Mahmoud, et al.
Expert Opinion on Drug Safety|February 18, 2020
Drug-induced myocardial dysfunction - recommendations for assessment in clinical and pre-clinical studiesAhmad Ebrahimi, Joel S Raichlen, Amy Pointon, et al.
Cell Biology and Toxicology|June 28, 2024
Computational approaches identify a transcriptomic fingerprint of drug-induced structural cardiotoxicityVictoria P W Au Yeung, Olga Obrezanova, Jiarui Zhou, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Archives of Toxicology|May 16, 2025
Discovering a predictive metabolic signature of drug-induced structural cardiotoxicity in cardiac microtissuesTara J Bowen, Andrew R Hall, Gavin R Lloyd, et al.
Stem Cell Reports|February 12, 2022
Deriving waveform parameters from calcium transients in human iPSC-derived cardiomyocytes to predict cardiac activity with machine learningHongbin Yang, Will Stebbeds, Jo Francis, et al.
Toxicology and Applied Pharmacology|December 12, 2022
Prediction of inotropic effect based on calcium transients in human iPSC-derived cardiomyocytes and machine learningHongbin Yang, Olga Obrezanova, Amy Pointon, et al.
Nature Communications|August 3, 2023
Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomicsTara J Bowen, Andrew D Southam, Andrew R Hall, et al.
Lab on a Chip|January 20, 2021
Cardiovascular microphysiological systems (CVMPS) for safety studies - a pharma perspectiveAmy Pointon, Jonathan Maher, Myrtle Davis, et al.
ALTEX|May 15, 2024
Application of microphysiological systems for nonclinical evaluation of cell therapiesPelin L Candarlioglu, Louise Delsing, Lauren Gauthier, et al.
Cell Stem Cell|February 17, 2024
Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytesKavita Raniga, Aishah Nasir, Nguyen T N Vo, et al.
Chemical Research in Toxicology|October 24, 2018
Information-Derived Mechanistic Hypotheses for Structural CardiotoxicityFredrik Svensson, Azedine Zoufir, Samar Mahmoud, et al.
Expert Opinion on Drug Safety|February 18, 2020
Drug-induced myocardial dysfunction - recommendations for assessment in clinical and pre-clinical studiesAhmad Ebrahimi, Joel S Raichlen, Amy Pointon, et al.
Cell Biology and Toxicology|June 28, 2024
Computational approaches identify a transcriptomic fingerprint of drug-induced structural cardiotoxicityVictoria P W Au Yeung, Olga Obrezanova, Jiarui Zhou, et al.
Pageof 4